Does INFLIXIMAB, RECOMBINANT Cause Drug ineffective? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Drug ineffective have been filed in association with INFLIXIMAB, RECOMBINANT. This represents 4.3% of all adverse event reports for INFLIXIMAB, RECOMBINANT.
11
Reports of Drug ineffective with INFLIXIMAB, RECOMBINANT
4.3%
of all INFLIXIMAB, RECOMBINANT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Drug ineffective From INFLIXIMAB, RECOMBINANT?
Of the 11 reports, 2 (18.2%) required hospitalization.
Is Drug ineffective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB, RECOMBINANT. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB, RECOMBINANT Cause?
Pneumocystis jirovecii pneumonia (29)
Off label use (21)
Infusion related reaction (18)
Histoplasmosis disseminated (16)
Tuberculosis (15)
Lupus-like syndrome (13)
Pulmonary tuberculosis (12)
Pneumonia (11)
Crohn's disease (9)
Disseminated tuberculosis (7)
What Other Drugs Cause Drug ineffective?
ADALIMUMAB (71,926)
METHOTREXATE (70,142)
ETANERCEPT (60,367)
ADAPALENE (52,181)
ABATACEPT (35,212)
INFLIXIMAB (33,738)
TOCILIZUMAB (32,342)
RITUXIMAB (32,186)
LEFLUNOMIDE (31,396)
HYDROXYCHLOROQUINE (31,057)
Which INFLIXIMAB, RECOMBINANT Alternatives Have Lower Drug ineffective Risk?
INFLIXIMAB, RECOMBINANT vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB, RECOMBINANT vs INFLUENZA VIRUS VACCINE
INFLIXIMAB, RECOMBINANT vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B
INFLIXIMAB, RECOMBINANT vs INGENOL MEBUTATE
INFLIXIMAB, RECOMBINANT vs INLYTA